Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|October 7, 2009
New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturationWade S Blair, Joan Cao, Juin Fok-Seang, et al.Antimicrobial Agents and Chemotherapy|October 28, 2005
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activityPatrick Dorr, Mike Westby, Susan Dobbs, et al.Methods in Enzymology|May 19, 2009
CCR5 pharmacology methodologies and associated applicationsRoy Mansfield, Sarah Able, Paul Griffin, et al.Antimicrobial Agents and Chemotherapy|February 3, 2016
Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant ConcentrationsMeizhen Feng, Nancy A Sachs, Min Xu, et al.Journal of Medicinal Chemistry|January 30, 2009
Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlaysLyn H Jones, Gill Allan, Oscar Barba, et al.Antiviral Therapy|May 11, 2011
Baseline CD4(+) T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patientsJonathan M Schapiro, Charles A B Boucher, Daniel R Kuritzkes, et al.Journal of Virology|October 5, 2012
Infection and propagation of human rhinovirus C in human airway epithelial cellsWeidong Hao, Katie Bernard, Nita Patel, et al.Antimicrobial Agents and Chemotherapy|March 10, 2022
Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to FluoroquinolonesGregory S Basarab, Sandeep Ghorpade, Liezl Gibhard, et al.Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Design and optimisation of potent gp120-CD4 inhibitorsThien-Duc Tran, Fiona M Adam, Frederick Calo, et al.Bioorganic & Medicinal Chemistry Letters|July 22, 2009
Discovery of a small molecule inhibitor through interference with the gp120-CD4 interactionDavid H Williams, Fiona Adam, David R Fenwick, et al.Pageof 5